<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00678522</url>
  </required_header>
  <id_info>
    <org_study_id>MED.RES.HOS.2006.04.LP</org_study_id>
    <nct_id>NCT00678522</nct_id>
  </id_info>
  <brief_title>The Acute Effect of Atorvastain on Renal Function in Patients With Type II Diabetes</brief_title>
  <official_title>The Acute Effect of Atorvastatin on Renal Sodium Excretion, Glomerular Filtration Rate, Tubular Function and Vasoactive Hormones in Patients With Non-Insulin Dependent Type II Diabetes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regional Hospital Holstebro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Regional Hospital Holstebro</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We wanted to test the hypothesis that acute treatment with atorvastatin changes renal sodium&#xD;
      excretion, glomerular filtration rate, tubular function and vasoactive hormones in patients&#xD;
      with type II diabetes, not in treatment with insulin.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>GFR, clearance of sodium and lithium, fractional excretion of sodium and lithium, U-AQP-2, total sodium excretion, albumin excretion rate and free water clearance.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>AVP, Ang-II, Aldo, ANP, BNP, PRC, BP, HR.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Healthy Subjects</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atorvastatin</intervention_name>
    <description>80 mg atorvastatin daily on two following days</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age: 40-70 yrs&#xD;
&#xD;
          2. estimated GFR between 30 and 90 ml/min&#xD;
&#xD;
          3. BMI&lt;35&#xD;
&#xD;
          4. Fertile women had to use oral contraceptives or IUD&#xD;
&#xD;
          5. HbA1c&lt; 10%&#xD;
&#xD;
          6. Urine-albumin&lt;1,5 g/l&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Treatment with insulin&#xD;
&#xD;
          2. Cerobrovascular insult or other disease of the brain&#xD;
&#xD;
          3. Insufficiency of the heart or lungs&#xD;
&#xD;
          4. Liverdisease with ALAT &gt; 200 U/L&#xD;
&#xD;
          5. hemoglobin &lt; 7,0 mmol/l&#xD;
&#xD;
          6. Cancer&#xD;
&#xD;
          7. Alcohol abuse&#xD;
&#xD;
          8. Medical treatment with psycopharmaca or/and analgetics&#xD;
&#xD;
          9. Pregnancy and breast feeding, 10 blood donation one month before the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erling B. Pedersen, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of medical reaserch, Holstebro Hospital, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Reseach, Holstebro Hospital</name>
      <address>
        <city>Holstebro</city>
        <zip>5500</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Medical Research, Holstebro Hospital</name>
      <address>
        <city>Holstebro</city>
        <zip>7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <study_first_submitted>May 13, 2008</study_first_submitted>
  <study_first_submitted_qc>May 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2008</study_first_posted>
  <last_update_submitted>May 14, 2008</last_update_submitted>
  <last_update_submitted_qc>May 14, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2008</last_update_posted>
  <responsible_party>
    <name_title>Lone Paulsen</name_title>
    <organization>Medical Research</organization>
  </responsible_party>
  <keyword>Atorvastatin</keyword>
  <keyword>Renal function</keyword>
  <keyword>Hemodynamics</keyword>
  <keyword>Diabetes type II</keyword>
  <keyword>sodium excretion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atorvastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

